课题基金 / 基金详情

Identification of the causative gene for inherited sideroblastic anemia and analysis of sideroblastis induced in vitro

Identification of the causative gene for inherited sideroblastic anemia and analysis of sideroblastis induced in vitro
遗传性铁粒幼细胞贫血致病基因的鉴定及体外诱导铁粒幼细胞的分析
批准号:
11670977
负责人:
HARIGAE Hideo
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

HARIGAE Hideo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
alas2 encodes the erythroid specific 8-aniinoleyuIinate synthase (ALAS2), the first enzyme in heme biosynthesis in erythroid cells. In vivo in mice, alas2-null primitive erythroblasts showed a maturation arrest as well as massive cytoplasmic iron accumulation. However, the effect of ALAS2 deficiency, on definitive erythropoiesis still remains unclear, because alas2-null mice died in utero by embryonic day 11.5 before definitive erythropoiesis developed. To clarity the effect of heme deficiency on differentiation of definitive erythroid cells, ES cells lacking the alas2 gene were induced to differentiate specifically into erythroid lineage in vitro, and phenotypes of definitive erythroblasts were examined. In comparison to red cell pellets of Wild-type erythroblasts, alas2-null definitive erythroblasts were totally white due to a marked deficiency of heme, although the morphology was similar to wild-type erythroblasts. Consistent with their similar morphology, levels of erythroid-specific gene expression such as GATA-1, NF-E2 andTER119 in alas2-null definitive erythroblasts were also similar to those of wild-type cells, indicating that both alas2-null and wild-type erythroblasts developed to the stage of mature definitive erythroblasts. In contrast to their similar morphology, however, iron content in alas2-null definitive erythroblasts was twice more than that of wild-type, cells. Consistent with the aberrant increase in iron content, alas2-null definitive erythroblasts were more oxidized compared with wild-type erythroblasts as judged by increased formation of peroxidized metabolites. These findings suggest that alas2 deficiency does not influence erythroid differentiation per se, but induces aberrant iron accumulation and oxidized condition in definitive erythroblasts.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
張替 秀郎 他: "Molecular analysis of δ-aminolevulinate dehydratase deficiency in a patient with an unusual lateonset porphyria"Blood. 96. 3618-3623 (2000)
Hideo Harikae 等人:“异常晚发性卟啉症患者 δ-氨基乙酰丙酸脱水酶缺乏症的分子分析”Blood. 96. 3618-3623 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
張替 秀郎 他: "遺伝性鉄芽球性貧血の分子診断とモデルマウス"臨床血液. 41. 540-543 (2000)
Hideo Harikae 等:“遗传性铁粒幼细胞贫血和小鼠模型的分子诊断”临床血液学 41. 540-543 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamamoto M, Nakajima O, Furuyama K, Harigae H, Hayashi N: "Molecular diagnosis of hereditary sideroblastic anemia and model mouse of the disease"Rinsho Ketsueki - Japanese Journal of Clinical Hematology. 41. 540-543 (2000)
Yamamoto M、Nakajima O、Furuyama K、Harigae H、Hayashi N:“遗传性铁粒幼细胞贫血的分子诊断和该疾病的模型小鼠”Rinsho Ketsueki - 日本临床血液学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
古山 和直他: "Multiple mechanisms for Hereditary Sideroblastic Anemia"Cellular and Molecular Biology. (印刷中). (2002)
Kazunao Furuyama 等人:“遗传性铁粒幼细胞贫血的多种机制”细胞和分子生物学(印刷中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Identification and functional analysis of erythroid-specific genes regulated by heme
    • 批准号:
      18591038
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.49万
    • 财政年份:
      2006
    • 负责人:
      HARIGAE Hideo
    • 依托单位:
    国内基金
    海外基金
    高等植物细胞色素b6f复合体血红素辅基Heme cn组装的分子机理研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      彭连伟
    • 依托单位:
    青蒿素类药物被heme激活后的代谢过程以及耐药疟原虫的代谢防御机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      邢杰
    • 依托单位:
    不依赖heme的脱羧酶undA的理性设计改造
    肉品中肌红蛋白Heme/Hemin辅基介导的肌球蛋白与水分子互作机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2021
    • 负责人:
    • 依托单位: